课题基金 / 基金详情

Chimaeric site-specific recombinases for 'genomic surgery'

Chimaeric site-specific recombinases for 'genomic surgery'
用于“基因组手术”的嵌合位点特异性重组酶
批准号:
BB/F021593/1
负责人:
Marshall Stark
金额:
$44.55万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Marshall Stark的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All living organisms contain immensely long double-helical DNA molecules that carry the information each cell needs to grow and multiply. This information is encoded in the sequence of the DNA building blocks called bases, strings of which encode messages known as genes. Cellular machines translate the code into useful molecules such as proteins. Sometimes we would like to 'edit' the DNA code; for example, by deleting a 'bad' gene that causes a disease, or by inserting a new gene that cures a disease or that makes an organism produce a useful substance such as an antibody. We are trying to develop tools for doing this DNA editing or 'genomic surgery', by modifying a class of natural proteins called site-specific recombinases which can already do reactions like this in bacteria. However, the bacterial enzymes only work at bacterial DNA sequences that they have evolved to recognize. In order to make them more generally useful, we must find a way of converting them so that they can recognize and 'cut and paste' at any DNA sequences that we choose. We have already demonstrated that one type of site-specific recombinase called resolvase can be modified so that it will act at a new sequence. To do this we replace the part of the resolvase protein that is designed to recognize the sequence of DNA bases with a DNA-recognizing module from another protein called Zif268. We call this hybrid protein a Z-resolvase. The Zif268 module is used because other research groups have worked out how to change it so that it can recognize almost any chosen DNA sequence of about 9 bases. We can therefore potentially make Z-resolvases that can be placed on any DNA target using their attached Zif268 module. However, there is still a lot to do before Z-resolvases can be used for very demanding applications, like curing human diseases, where any editing of the wrong DNA sequences could be disastrous. In this project, we want to develop Z-resolvases so that they work on almost any chosen DNA sequence with the efficiency and precision necessary for real uses in biotechnology and gene therapy. To reach this goal we will have to optimize the properties of Z-resolvase. We need to modify the part of Z-resolvase that actually breaks and rejoins DNA strands, so that it can deal with any DNA sequence that it is placed on. We must ensure that our Z-resolvase proteins are very specific for the chosen sequence, and do not damage the DNA elsewhere. We want to be able to control the type of changes in the DNA that a Z-resolvase brings about; for example, to make sure that it cuts a section out and does not put it back in. Finally, we must make sure that Z-resolvases work efficiently in humans and other species where they might be used. To test whether we have achieved these objectives, we aim to demonstrate that we can use Z-resolvases to cut out the piece of DNA encoding HIV (the virus that causes AIDS in humans) from a cell's DNA, thus preventing it from making more virus copies.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0019537
发表时间: 2011-04-29
期刊: PloS one
影响因子: 3.7
作者: [Proudfoot C, McPherson AL, Kolb AF, Stark WM]
通讯作者: Stark WM
DOI: 10.1128/9781555817954
发表时间: 2002
期刊:
影响因子: --
作者: [N. Craig;M. Chandler;M. Gellert;A. Lambowitz;P. Rice;S. Sandmeyer]
通讯作者: N. Craig;M. Chandler;M. Gellert;A. Lambowitz;P. Rice;S. Sandmeyer
DOI: 10.1093/nar/gkr652
发表时间: 2011-11
期刊: Nucleic acids research
影响因子: 14.9
作者: [Prorocic MM, Wenlong D, Olorunniji FJ, Akopian A, Schloetel JG, Hannigan A, McPherson AL, Stark WM]
通讯作者: Stark WM
Elucidation of the rotary mechanism of serine recombinases
  • 批准号:
    BB/R008493/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.24万
  • 财政年份:
    2018
  • 负责人:
    Marshall Stark
  • 依托单位:
A platform for rapid and precise DNA module rearrangements in Synthetic Biology
  • 批准号:
    BB/K003356/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $416.07万
  • 财政年份:
    2013
  • 负责人:
    Marshall Stark
  • 依托单位:
The mechanism of DNA strand exchange by serine recombinases
  • 批准号:
    BB/E022200/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $48.63万
  • 财政年份:
    2007
  • 负责人:
    Marshall Stark
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
  • 批准号:
    82370790
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    叶蕾
  • 依托单位:
具有共形结构的高性能Ta4SiTe4基有机/无机复合柔性热电薄膜
棕色脂肪细胞脂滴与线粒体锚定的功能与机制研究
  • 批准号:
    32100557
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    崔留娟
  • 依托单位: